The Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) has launched a new eLearning portal designed to accelerate the adoption of pharmacogenomics (PGx) in real-world clinical practice.
Led by the University of Liverpool in partnership with the British Pharmacological Society (BPS) and Queen Mary University of London, the portal offers free, bite-sized online learning tailored for healthcare and regulatory professionals. The platform aims to build confidence and capability in applying PGx to improve therapeutic outcomes.
Funded by Innovate UK and led by Professor Sir Munir Pirmohamed, CERSI-PGx is committed to driving forward education that supports the delivery of medicines "fit for the genome". The newly launched course represents a major step in empowering clinicians, prescribers and decisionmakers to integrate genomic insights into everyday prescribing.
The University of Liverpool's Dr Maria Tsakiroglou, who led on this work, said: "As the NHS advances toward genomic-based healthcare and pharmacogenomic (PGx)-guided prescribing becomes a clinical reality, equipping stakeholders with the right skills is essential. The CERSI-PGx eLearning portal provides accessible, free and bite-sized training through user-directed modules delivered via a range of engaging formats."
The launch of the CERSI-PGx eLearning portal marks an important milestone in advancing genomic literacy across the healthcare landscape-supporting safer, more effective, and more personalised prescribing for patients.
Access to the CERSI-PGx course is completely free. Learners can begin in just a few steps:
Access the CERSI-PGx Learning Portal
